MAP2K7 and acute lymphoblastic leukemia: The fact that pevonedistat induced UPR-mediated cell death via de-phosphorylation of p-eIF2α (Ser51) in ALL cells, altering the UPR regulation of protein translation [4], prompted us to examine its role in pevonedistat-induced CRAC/MEK/ERK pathway activation.